| Literature DB >> 35455048 |
Masahiro Tominaga1,2, Akihiko Kondo1,2,3,4, Jun Ishii1,2.
Abstract
Transcriptional switches can be utilized for many purposes in synthetic biology, including the assembly of complex genetic circuits to achieve sophisticated cellular systems and the construction of biosensors for real-time monitoring of intracellular metabolite concentrations. Although to date such switches have mainly been developed in prokaryotes, those for eukaryotes are increasingly being reported as both rational and random engineering technologies mature. In this review, we describe yeast transcriptional switches with different modes of action and how to alter their properties. We also discuss directed evolution technologies for the rapid and robust construction of yeast transcriptional switches.Entities:
Keywords: directed evolution; genetic switch; synthetic promoter; synthetic transcription factor; transcriptional switch; yeast
Year: 2022 PMID: 35455048 PMCID: PMC9030632 DOI: 10.3390/life12040557
Source DB: PubMed Journal: Life (Basel) ISSN: 2075-1729
Figure 1Construction of yeast genetic switches using synthetic transcriptional activators or bare transcription factors. Inducer-ON and inducer-OFF types of genetic switches can be constructed using sTA (A,B) and intact bacterial repressors (C,D), respectively. Abbreviations: Core prom, Core promoter; eTA, eukaryotic transcription activator; GOI, gene of interest; revTF, reverse transcription factor; RNAP, RNA polymerase; synP, synthetic promoter; sTA, synthetic transcription activator; TATA, TATA Box; TF, transcription factor.
Examples of transcriptional switches based on synthetic transcription activators.
| Inducer a | bTF | bTF Type c | Source | Additional Motif d | Operators e | CoreP f | Reference |
|---|---|---|---|---|---|---|---|
| Dox | Reversed TetR (rTetR) | Co-rep |
| VP16 × 3 | [ |
| [ |
| Dox | rTetR | Co-rep |
| VP16 × 3 | [ |
| [ |
| Dox | rTetR | Co-rep |
| VP16 × 3 | [ |
| [ |
| Dox | TetR | Rep |
| VP16ad × 1 or 2 | [ |
| [ |
| DAPG | PhlF | Rep |
| VP16 × 3 | [ |
| [ |
| NLS, VP16 × 3 | [ |
| [ | ||||
| Camphor | CamR | Rep |
| NLS, VP16 × 3 | [ |
| [ |
| [ |
| [ | |||||
| Cumate | CymR | Rep |
| NLS, VP16 * | [ |
| [ |
| DAPG | Reversed PhlF (rPhlF) | Rep |
| NLS, VP16 × 3 | [ |
| [ |
| HSL | LuxR | Act |
| NLS, VP16 × 3 | [ |
| [ |
| [ |
| ||||||
| [ |
| ||||||
| SAM | MetJ | Co-Rep |
| NLS, B42 | [ |
| [ |
| Methylating compound | N-Ada b | Act |
| GAL4-AD | [ |
| [ |
| Xylose | XylR | Act |
| NLS, VPRH |
| [ | |
| NLS, VPRH | [ |
| |||||
| NLS, VPR | ND | ND | |||||
| NLS, HSF | ND | ND | |||||
| NLS, VPRH | [ |
| |||||
| NLS, VPRH | [ |
| |||||
| NLS, VPRH | [ |
| |||||
| Malonyl-CoA | FapR | Rep |
| Prm1 | [ |
| [ |
| Benzoate | HbaR | Act |
| B112 | [LexA binding site]8 |
| [ |
a. Doxycycline, Dox; DAPG, 2,4-diacetylphloroglucinol; HSL, homoserine lactone; SAM, S-adenosyl methionine. b. N-Ada, N-terminal 180 amino acids of Ada protein from E. coli. c. Co-rep, co-repressor; Rep, repressor; Act, activator. d. VP16 and VP16ad, Transcription activation domain of VP16 from herpes simplex virus 2 (VP16: residues from 436 to 447, and VP16ad: residues 367 to 490); NLS, Nuclear localization signal from Simian Vacuolating Virus 40; B42 and B112, transcription activation domain from E. coli; GAL4-AD, Activation domain of GAL4 (residues from 767 to 881) from S. cerevisiae; VPRH, a fusion of 4×VP16 (VP64), a 65 kDa transcription activator domain of human NF-κB (p65), an Rta protein from Epstein–Barr virus, and transactivation domain of human Heat shock factor 1 (HSF); VPR, a fusion of VP64, p65, and Rta; Prm1, transcription activator protein from Komagataella phaffii. VP16 *, the number of VP16 repeats is not described. e. The number of transcription factor binding sequences (operators) is shown as a subscript. LexA, a bacterial transcription repressor; AdaOp, Ada operator, Pup-[Pxo]1, synthetic hybrid promoter without lacking UAS of TEF promoter; Pxo, 240-bp promoter sequence including XylR binding sequence from E. coli. ND, Not described. f. Source organism for each core promoter (coreP) is shown in parenthesis. Sc, S. cerevisiae; Yl, Yarrowia lipolytica; Kp, Komagataella phaffii. ND, Not described.
Figure 2Yeast genetic switches based on eukaryotic ligand-binding proteins. (A) The nuclear localization of sTA, which consists of a eukaryotic hormone receptor, a DNA binding domain (DBD) and eTA (VP16), is inhibited by Hsp90p. Upon ligand binding to a hormone receptor, sTA releases from Hsp90p and is localized to the nucleus to activate target promoter transcription. (B) Hormone receptor protein hER fused with a DBD binds Src1 only when its agonist hormone is present, activating target gene transcription by recruiting eTA fused with Src1 to the target binding sequence upstream of the promoter. Abbreviations: DBD, DNA binding domain; GOI, gene of interest.
Figure 3Transcription activation based on intact bacterial transcription activators. Ligand binding to transcription activators induces conformational changes to promoters and the recruitment of RNA polymerase. Abbreviations: GOI, gene of interest; RNAP, RNA polymerase; synP, synthetic promoter TATA, TATA box; TF, transcription factor.
Examples of yeast transcriptional switches based on bacterial repressors.
| Inducer a | bTF | Source of bTF and Operator | Additional Motif b | Operators | Yeast Promoter d | Reference |
|---|---|---|---|---|---|---|
| aTc | TetR |
| NLS | [ | [ | |
| aTc | TetR |
| – | [ | [ | |
| aTc | TetR |
| – | [ |
| [ |
| DAPG | PhlF |
| NLS | [ |
| [ |
| Vanilic acid | VanR |
| – | [ |
| [ |
| Vanillin | ||||||
| Naringenin | FdeR |
| NLS | [ | [ | |
| Fatty acids | FadR |
| NLS | [ | [ | |
|
| – | [ | ||||
| Malonyl-CoA | FapR |
| Prm1 | [ | [ | |
|
| NLS | [ | [ | |||
|
| NLS | [ | [ | |||
| Xylose | XylR |
| NLS | [ |
| [ |
|
| ||||||
|
| ||||||
|
| ||||||
|
| ||||||
|
| ||||||
|
| NLS | [ | [ | |||
|
| NLS | [ | ||||
|
| NLS | [ | ||||
|
| NLS, Ssn6 | [ |
| [ | ||
|
| NLS | [ | [ | |||
|
| NLS | [ | ||||
|
| NLS | [ | ||||
| IPTG | LacI |
| NLS | [ | [ | |
| NLS | [ |
| [ | |||
| – | [ |
| [ | |||
| NLS | [ | [ |
a. Anhydrotetracycline hydrochloride, aTc; DAPG, 2,4-diacetylphloroglucinol; IPTG, isopropyl-β-D(-)-thiogalactopyranoside. b. NLS, Nuclear localization signal from Simian Vacuolating Virus 40; Ssn6, Transcriptional co-repressor from S. cerevisiae; Prm1, transcription activator protein from Komagataella phaffii. c. Four types of operator positions were evaluated: downstream of TATA box, downstream of UAS, upstream of TATA box, both downstream of UAS and upstream of TATA box. d. Source organism for each yeast promoter is shown in parenthesis. Sc, S. cerevisiae; Kp, Komagataella phaffii; Szp, Schizosaccharomyces pombe; Ag, Ashbya gossypii. e. P, P, and P are completely synthetic promoters, where two operator sequences are separated by a poly (T) sequence, followed by the transcription start site. f. PT and PL are a completely synthetic promoter, where two tetO sequences are flanked by the randomized sequences. g. Hybrid promotor consisting of the upstream enhancer element of TEF1 promoter (UEE) from S. cerevisiae and modified GAL1 core promoter (P) from S. cerevisiae was used.
Figure 4Engineering strategy for yeast genetic switches with different modes of action. (A) A dose-response curve for a representative “inducer-ON” switch is shown. To evaluate switching performance, reporter gene expression in the presence of different concentrations of inducer is quantified and the resultant data are fitted to the equation to obtain the response function. Strategies to alter the response function of yeast genetic switches with an activation/deactivation mode (B) and repression/de-repression mode (C) are illustrated. Abbreviations: eTA, eukaryotic transcription activator; eTR, eukaryotic transcription repressor; GOI, gene of interest; NLS, nuclear localization signal; synP, synthetic promoter; sTA, synthetic transcription activator; sTR, synthetic transcription repressor; TATA, TATA Box; TF, transcription factor.
Figure 5Yeast genetic circuits that increase induction-fold. (A) Yeast transcriptional switch that uses both activation/deactivation and repression/de-repression modes of regulation. (B). Transcription cascade that amplifies inducer-triggered expression switching. (C). Yeast genetic switch that uses both sTA and sTR. Abbreviations: eTA, eukaryotic transcription activator; GOI, gene of interest; synP, synthetic promoter; sTA, synthetic transcription activator; sTR, synthetic transcription repressor; TF, transcription factor.
Figure 6Chemical structure of inducers for wild-type and mutant hERα (A), VanR (B), and BenM (C).